Skip to main content
Search
Main content
Journal of neurology, neurosurgery, and psychiatry
Published

The study of epigenetic clocks in former professional contact sports athletes with repetitive head impacts

Authors

Xuelin Tang, Vishaal Sumra, Christine Sato, Danielle Moreno, Mozhgan Khodadadi, Nusrat Sadia, Carmen Wong, Brenda Colella, Robin E A Green, Janet Ta, Kaj Blennow, Henrik Zetterberg, Richard Wennberg, Charles H Tator, Ming Zhang, Ekaterina Rogaeva, Maria Carmela Tartaglia

Abstract

J Neurol Neurosurg Psychiatry. 2026 May 11:jnnp-2025-338206. doi: 10.1136/jnnp-2025-338206. Online ahead of print.

ABSTRACT

BACKGROUND: Repetitive head impacts in former contact sport athletes are associated with cognitive impairment, accelerated cerebral atrophy and risk of neurodegenerative disease. Epigenetic clocks derived from age-associated DNA methylation (DNAm) profiles may capture accelerated biological ageing in neurodegenerative conditions; however, their application in former athletes remains unexplored. Here we aim to explore the application of epigenetic clocks as a measure of accelerated biological ageing in a cohort of former athletes.

METHODS: In 126 former athletes (96% male; mean age: 54.5±14.4 years; mean concussions: 6.8±6.7), we examined associations of brain volumes, plasma neurofilament light levels and cognitive/behavioural scores with DNAmAge-acceleration, AgeAccelResidual and DNAmFitAge-acceleration.

RESULTS: We only found an association between the number of concussions and DNAmFitAge-acceleration (p=0.003, B=0.46, R²=0.063), indicating that every two additional concussions were associated with a 5-year increase in DNAmFitAge-acceleration. There was also a trend towards an association between years of play and DNAmAge-acceleration in older athletes.

CONCLUSIONS: These preliminary findings suggest that specific epigenetic clock measures may serve as early markers of biological ageing related to repetitive head impacts.

PMID:42114983 | DOI:10.1136/jnnp-2025-338206

UK DRI Authors

Prof Henrik Zetterberg

Group Leader

Pioneering the development of fluid biomarkers for dementia

Prof Henrik Zetterberg